Pharmaceutical companies clawed back losses suffered yesterday, but the FTSE 100 index is little cha...
Pharmaceutical companies clawed back losses suffered yesterday, but the FTSE 100 index is little changed, up 4 points to 3,933. The latest house price survey from Nationwide indicates house price inflation is coming down, which could translate into lower future consumer spending, but this is countered by yesterday's figures showing consumers spending in April rebounded strongly from falls in February and March. But medicine still looked like a safe-haven this morning. Amersham leads the gainers with a 24p rise to 445.5p. AstraZenica, one of yesterday's losers, is...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes